Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients
- PMID: 39731391
- PMCID: PMC12129717
- DOI: 10.1111/ceo.14488
Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients
Abstract
Background: To evaluate the clinical presentation, pathological features and outcomes of retinoblastoma based on the race of origin in a global cohort of patients.
Methods: Retrospective collaborative study of 1426 patients who underwent primary enucleation for retinoblastoma.
Results: Patients were grouped into Caucasians (n = 231, 16%), Asians (n = 841, 59%), Hispanics (n = 226, 16%), Arabs (n = 96, 7%) and Others (Africans, African Americans, Indigenous Australians; n = 32, 2%) cohorts. On histopathology, massive choroidal invasion was higher in Asians (30%) and Hispanics (26%) than Caucasians (15%, p < 0.001). Post-laminar optic nerve invasion was higher in Asians (28%), Hispanics (20%) and Others (9%) than Caucasians (11%, p < 0.001). At a mean follow-up of 41 months (median, 35 months; range, < 1-149 months), tumour recurrence and metastasis-related death was higher in Hispanics (9% and 12%, respectively), Asians (4% and 13%, respectively) and Others (6% and 6%, respectively). Multivariate Cox proportional hazards analysis of outcomes based on race with 8th edition AJCC pT stage and adjuvant therapy as covariates revealed 6.8 times greater risk for orbital tumour recurrence in Hispanics compared to Caucasians (p = 0.010) and 3.2 times risk hazards for metastasis-related death in Hispanics and Asians compared to Caucasians (p = 0.028 and p = 0.038, respectively).
Conclusion: The histopathological features in primarily enucleated eyes with retinoblastoma vary with race. Despite adjusting for tumour staging and adjuvant treatment, race remains an independent predictor of outcomes, including orbital tumour recurrence and metastasis-related death. A stringent follow-up and a more aggressive treatment approach is recommended in Asians and Hispanics who manifest high-risk histopathological features.
Keywords: global study; high‐risk features; histopathological features; race; retinoblastoma.
© 2024 The Author(s). Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Tomar A. S., Finger P. T., Gallie B., et al., “American Joint Committee on Cancer Ophthalmic Oncology Task Force. Global Retinoblastoma Treatment Outcomes: Association With National Income Level,” Ophthalmology 128, no. 5 (2021): 740–753. - PubMed
-
- Canturk S., Qaddoumi I., Khetan V., et al., “Survival of Retinoblastoma in Less‐Developed Countries Impact of Socioeconomic and Health‐Related Indicators,” British Journal of Ophthalmology 94, no. 11 (2010): 1432–1436. - PubMed
-
- Wong E. S., Choy R. W., Zhang Y., et al., “Global Retinoblastoma Survival and Globe Preservation: A Systematic Review and Meta‐Analysis of Associations With Socioeconomic and Health‐Care Factors,” Lancet Global Health 10, no. 3 (2022): e380–e389. - PubMed
-
- Kaliki S., Vempuluru V. S., Mohamed A., et al., “Global Retinoblastoma Study Group. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients From 33 Countries,” Ophthalmology 131, no. 4 (2024): 468–477. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
